J4 ›› 2014, Vol. 13 ›› Issue (4): 41-43.

Previous Articles     Next Articles

Comparative Study on the Treatments for Hand- foot -mouth Disease in Children with Human Recombinant Interferon alph-1b and Ribavirin Respectively

  

  1. Dali Teaching Hospital of Dali University,Dali,Yunnan 671000,China
  • Received:2013-09-09 Online:2014-04-15 Published:2014-04-15

Abstract:

Objective:To discuss the effect and safety of the treatment for children's hand- foot -mouth disease with human
recombinantinterferon alph-1b. Methods:388 cases of children with hand-foot -mouth disease were randomly divided into two groups which were given the same support and symptomatic treatment. Treatment group,184 cases were treated with human recombinant interferon alph-1b,< 1,1 ug(kg·d),intramuscular,2~10 10 ug/d muscle injection,1 times a day. The control group, 204 cases were treated with ribavirin〔10~15 mg /(kg·d)〕an intravenous drip. Results:The treatment group was better than control group (P<0.01)in the defervescence time,hand,foot and skin rash and mouth ulcer healing. In addition to that the individual children have a fever;there was no obvious side effect in the treatment group. Conclusion:Interferon treatment of hand,foot and mouth disease in children is safe and effective,and is worth popularizing clinically used.

Key words: interferon, ribavirin, hand-foot- mouth disease, children

CLC Number: